Elekta Flexitron brachytherapy treatment delivery available in China
China Food and Drug Administration (CFDA) approves cancer treatment system
BEIJING, Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announces that the China Food and Drug Administration (CFDA) has approved Elekta's Flexitr... Devices, Oncology, RegulatoryElekta, Flexitron, brachytherapy, afterloading
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Marketing | Pharmaceuticals